18FDG-PET imaging and histopathology in neuroleukemiosis with acute myeloid leukemia Yusuke KiyokiRyota MatsuokaHidekazu Nishikii Images in Hematology 31 August 2020 Pages: 433 - 434
Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry Aya NakayaTakae KoharaKansai Myeloma Forum Investigators Rapid Communication 21 September 2020 Pages: 435 - 438
JSH practical guidelines for hematological malignancies, 2018: I. leukemia—3. acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL) Yoshihiro HattaFumihiko HayakawaEtsuko Yamazaki Guideline 18 August 2020 Pages: 439 - 458
Cutaneous manifestations of B-cell chronic lymphocytic leukemia Elena A. MorozovaOlga Yu. OlisovaEugene A. Nikitin Review Article 05 September 2020 Pages: 459 - 465
Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients Ken IshiyamaShinji NakaoShinichiro Okamoto Original Article 31 August 2020 Pages: 466 - 476
New insights on patient-related risk factors for venous thromboembolism in patients with solid organ cancers Aditya KotechaDeepa RaghavanCamelia Arsene Original Article 06 July 2020 Pages: 477 - 486
Acute myeloid leukemia during pregnancy: a single institutional experience with 17 patients and literature review Yi-Wei LiYang-Feng XuCan Chen Original Article 18 July 2020 Pages: 487 - 495
Development of anti-human CADM1 monoclonal antibodies as a potential therapy for adult T-cell leukemia/lymphoma Syahrul ChilmiShingo NakahataKazuhiro Morishita Original Article 12 July 2020 Pages: 496 - 503
Phase I study of duvelisib in Japanese patients with relapsed or refractory lymphoma Koji IzutsuKoji KatoKoichi Akashi Original Article 01 July 2020 Pages: 504 - 509
Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies Naoyuki UchidaKana Matsumotofor the Japan Study Group for Cell Therapy, Transplantation (JSCT) Original Article 12 July 2020 Pages: 510 - 523
Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group Sachie KasaiHidehiro ItonagaYasushi Miyazaki Original Article 25 June 2020 Pages: 524 - 534
Differences among hemoglobin thresholds for red blood cell transfusions in patients with hematological diseases in teaching hospitals: a real world data in Japan Akihiko YokohamaYoshiki OkuyamaKazuo Muroi Original Article 18 July 2020 Pages: 535 - 543
Potential role of Howell−Jolly bodies in identifying functional hyposplenism: a prospective single-institute study Yuya NakagamiKaori UchinoAkiyoshi Takami Original Article 23 June 2020 Pages: 544 - 552
Changes of hematological and immunological parameters in COVID-19 patients Xiaohong YuanWanling HuangJianda Hu Original Article 12 July 2020 Pages: 553 - 559
Analysis of the BRAF and MAP2K1 mutations in patients with Langerhans cell histiocytosis in Japan Tomomi HayaseShiori SaitoAkira Morimoto Original Article 11 July 2020 Pages: 560 - 567
Short-term effectiveness of ruxolitinib in the treatment of recurrent or refractory hemophagocytic lymphohistiocytosis in children Ang WeiHonghao MaTianyou Wang Original Article 14 July 2020 Pages: 568 - 576
Nausea and vomiting during post-transplantation cyclophosphamide administration Toshihisa NakashimaYoshihiro InamotoMasakazu Yamaguchi Original Article 12 July 2020 Pages: 577 - 583
Pathological findings suggesting vascular endothelial damage in multiple organs in chronic myelogenous leukemia patients on long-term tyrosine kinase inhibitor therapy Yoshinobu SekiOuki NaganoGo Hasegawa Case Report 18 June 2020 Pages: 584 - 591
Extranasal extranodal NK/T-cell lymphoma associated with systemic lupus erythematosus Satoshi IchikawaNoriko FukuharaHideo Harigae Case Report 08 June 2020 Pages: 592 - 596
Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab Ciprian TomuleasaSabina IlutaBobe Petrushev Letter to the Editor 04 September 2020 Pages: 597 - 598
Correction to: Menatetrenone facilitates hematopoietic cell generation in a manner that is dependent on human bone marrow mesenchymal stromal/stem cells Aya FujishiroMasaki IwasaYasuo Miura Correction 15 September 2020 Pages: 599 - 602
